Castle Biosciences IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 26.79 USD | 44,28 USD | 14,59 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 42,778 USD | 8 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 30.329.952 | 4,8 | 3,98 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Castle Biosciences Inc
Mitarbeiter 942
Handelsplatz NASDAQ
Ticker Symbol CSTL
IPO Datum 2019-07-25
Adresse 1500 W. Parkwood Ave, Friendswood, TX, United States, 77546
Webseite https://castlebiosciences.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Derek J. Maetzold | Founder, CEO, President & Director |
| 2 | Mr. Frank Stokes | CFO & Treasurer |
| 3 | Ms. Kristen M. Oelschlager R.N. | Chief Operating Officer |
| 4 | Mr. Tobin W. Juvenal | Chief Commercial Officer |
| 5 | Ms. Camilla Zuckero | Vice President of Investor Relations & Corporate Affairs |
| 6 | Mr. Kevin Doman | Vice President of Sales |
| 7 | Dr. Jay Braxton Pharm.D. | VP of Marketing & Brand Manager of Uveal Melanoma (UM) |
| 8 | Ms. Keli Greenberg | Vice President of Human Resources |
| 9 | Dr. Matthew Goldberg M.D. | Senior Vice President of Medical |
| 10 | Ms. Trisha Poteet | Senior VP of Clinical Services & Manufacturing Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Principal Financial Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Portolan Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 8 | Summit Partners Public Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Allianz Asset Management AG | 0,00% | 0,00 Mio. USD |
| 11 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 12 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | AIGH Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 15 | Palisade Capital Management LLc | 0,00% | 0,00 Mio. USD |
| 16 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 17 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 20 | Eventide Asset Management, LLC | 0,00% | 0,00 Mio. USD |